The leading event for biologics de-risking, immunoassay validation
and predicting immunogenicity in novel, highly complex molecules

The 2013 Immunogenicity event was a great success and featured:

  • Three FDA keynote speakers - An in-depth insight from FDA regulators, featuring the release of draft guidelines for biosimilar development
  • Immunogenicity University - Back by popular demand, this intensive full-day summit dives into the fundamentals of immunogenicity assessment, statistical analysis and assay design beneficial for experts at all levels of their career
  • Increased Networking Opportunities - You'll have 8+ hours of networking opportunity, including a Wine and Cheese Reception where scientists can link-up with lab technicians, research providers and regulatory consultants

We are hard at work on next year's event, so make sure to sign up for event updates to receive up-to-date information. If you are interested in speaking opportunities, please contact Megan Knapp at 212-661-2012 or mknapp@iirusa.com

To discuss sponsorship and exhibition options, please contact Casey Burwell, Sales Manager

I was particularly impressed by this event's extremely high standards for speakers, panel discussions, networking and audience feedback.

-Harald Kropshofer
Senior Personalized Healthcare Leader
©2012 IIR HOLDINGS, LTD. All Rights Reserved.